
ORGN
Origin Materials Inc.
$1.45
-$0.08(-5.23%)
35
Overall
60
Value
16
Tech
31
Quality
Market Cap
$79.45M
Volume
84.32K
52W Range
$1.22 - $28.49
Target Price
$0.50
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | -- | -- | $28.8M | $31.3M | $18.9M | ||
| Total Revenue | -- | -- | -- | $28.8M | $31.3M | $18.9M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | -- | -- | -- | $23.6M | $30.9M | -- | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | -- | -- | $28.8M | $31.3M | $18.9M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $11.2M | $26.9M | $38.9M | $60.1M | $85.3M | $259.6M | ||
| Research & Development | $4.1M | $9.1M | $14.1M | $21.4M | $18.6M | $13.7M | ||
| Research Expense | $4.1M | $9.1M | $14.1M | $21.4M | $18.6M | $13.7M | ||
| Selling, General & Administrative | $6.6M | $17.3M | $24.1M | $35.4M | $40.8M | $39.1M | ||
| General & Administrative Expenses | $6.6M | $17.3M | $24.1M | $35.4M | $40.8M | $39.1M | ||
| Salaries & Wages | $1.6M | $5.8M | $7.2M | $9.4M | -- | -- | ||
| Depreciation & Amortization | $479.0K | $544.0K | $711.0K | $3.4M | -- | -- | ||
| Depreciation & Amortization | $479.0K | $544.0K | $711.0K | $3.4M | -- | -- | ||
| Other Operating Expenses | -- | $392.0K | $778.0K | $60.1M | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-11.2M | $-26.9M | $-38.9M | $-54.9M | $-84.9M | $-259.1M | ||
| EBITDA | $-29.5M | $45.8M | $79.9M | $26.2M | $-71.9M | $-237.8M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $341.0K | $2.8M | -- | $131.0K | $371.0K | $123.0K | ||
| Intinc | $212.5K | $1.4M | $300.0K | $600.0K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-341.0K | $-1.4M | $-8.8M | $600.0K | $-371.0K | $-123.0K | ||
| Gain on Sale of Securities | -- | $200.0K | $-1.0M | $1.0M | -- | -- | ||
| Other Income/Expense | $-19.6M | $69.6M | $108.7M | $-838.0K | $939.0K | $726.0K | ||
| Other Special Charges | $19.6M | $-69.6M | $117.5M | $838.0K | $-939.0K | $-726.0K | ||
| SPECIAL ITEMS | ||||||||
| Special Income Charges | $805.0K | $811.0K | $-213.0K | $-233.0K | $-15.2M | $-195.6M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | $15.2M | $195.6M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-30.0M | $44.9M | $78.6M | $22.7M | $-82.7M | $-249.0M | ||
| Pre-Tax Income | $8.9M | $-97.2M | $78.6M | $22.7M | $-83.0M | $-249.1M | ||
| INCOME TAX | ||||||||
| Tax Provision | -- | $-563.0K | -- | $-1.1M | $669.0K | $621.0K | ||
| NET INCOME | ||||||||
| Net Income | $-30.3M | $42.1M | $78.6M | $23.8M | $-83.7M | $-249.7M | ||
| Net Income (Continuing Operations) | $-30.3M | $42.1M | $78.6M | $23.8M | $-83.7M | $-249.7M | ||
| Net Income (Discontinued Operations) | $-30.3M | $42.1M | $78.6M | $23.8M | $-83.7M | $-249.7M | ||
| Net Income (Common Stockholders) | $-30.3M | $42.1M | $78.6M | $23.8M | $-83.7M | $-249.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-51.0M | ||
| TOTALS | ||||||||
| Total Expenses | $11.2M | $26.9M | $38.9M | $60.1M | $85.3M | $259.6M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $613.4K | $3.4M | $4.6M | $4.7M | $4.8M | $4.9M | ||
| Average Shares Outstanding (Diluted) | $1.2M | $3.5M | $4.7M | $4.8M | $4.8M | $4.9M | ||
| Shares Outstanding | $5.5M | $4.7M | $4.8M | $4.9M | $5.0M | $5.4M | ||
| Basic EPS | $-0.60 | $12.6 | $17.1 | $5.1 | $-17.4 | $-50.55 | ||
| Basic EPS (Continuing Operations) | $-0.60 | $12.6 | $17.1 | $5.1 | $-17.4 | $-50.55 | ||
| Diluted EPS | $-0.60 | $12 | $16.5 | $5.1 | $-17.4 | $-50.55 | ||
| Diluted EPS (Continuing Operations) | -- | $12 | $16.5 | $5.1 | $-17.4 | $-50.55 | ||
| OTHER METRICS | ||||||||
| Acquisition Expense | -- | $36.7M | $36.7M | -- | -- | -- | ||
| Excise Taxes | -- | -- | -- | -- | $10.7M | $11.2M | ||
| Loss And Loss Adjustment Expected Incurred | -- | -- | -- | -- | $10.7M | -- | ||
| Non Recurring Operation Expense | $-805.0K | $-811.0K | $-1.7M | -- | -- | -- | ||
| Other Gand A | $6.6M | $17.3M | $24.1M | $35.4M | $40.8M | $39.1M | ||
| Othspecchg | -- | -- | $213.0K | $233.0K | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORGN | $1.45 | -5.2% | 84.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |